CAPLIPOINT.BO BSE
Caplin Point Laboratories Ltd.
1W: -8.2%
1M: -3.1%
3M: +3.8%
YTD: +52.0%
₹2,634.00 ($27.35)
-74.80 (-2.76%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$5.8B
+35.2% ▲
Capital Expenditures
$2.5B
-29.6% ▼
Free Cash Flow
$3.4B
+39.8% ▲
Dividends Paid
$456M
-20.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$4.2B
+589.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2025 | FY2026 |
|---|---|---|
| — Operating Activities — | ||
| Net Income | $5.4B | $6.4B |
| Depreciation & Amort. | $660M | $728M |
| Stock-Based Comp. | $94M | $0 |
| Change in Working Capital | -$1.2B | -$1.1B |
| Other Non-Cash Items | -$570M | -$203M |
| Operating Cash Flow | $4.3B | $5.8B |
| — Investing Activities — | ||
| Capital Expenditures | -$1.9B | -$2.5B |
| Acquisitions (Net) | $0 | -$500K |
| Investment Purchases | -$2.2B | -$4.0B |
| Investment Sales | $260M | $55M |
| Other Investing | $517M | $11M |
| Investing Cash Flow | -$3.3B | -$6.4B |
| — Financing Activities — | ||
| Net Debt Issuance | $3M | $200K |
| Stock Repurchased | $0 | $0 |
| Dividends Paid | -$380M | -$456M |
| Other Financing | -$6M | $0 |
| Financing Cash Flow | -$383M | -$456M |
| Net Change in Cash | $608M | $4.2B |
| Cash End of Period | $2.0B | $6.2B |
| Free Cash Flow | $2.4B | $3.4B |